 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.

Market Cap	$2.32M
Volume (M)	30,597.00
52-Wk High	$0.0196
52-Wk Low	$0.0032

Current Price	$0.0048
Prev Close	$0.0047
Open	$0.0047
Dividend Yield	0.00%
50-Day Moving Average	$0.0068
Beta	-0.19
Avg. Volume	593,092.38
PE Ratio	-5.00

52-Week High	$0.0196
52-Week Low	$0.0032
Market Capitalization	$2.32M
EPS	-$0.0009
Price to Book	-2.74
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-12.63

HALB Halberd Corp

About

Feed

News

Fundamentals